Medication Therapy Management
"Medication Therapy Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.
| Descriptor ID |
D054539
|
| MeSH Number(s) |
N02.421.668.438 N03.219.521.576.343.575.500.500 N03.219.521.576.343.840.938.500 N04.590.661
|
| Concept/Terms |
Medication Therapy Management- Medication Therapy Management
- Management, Medication Therapy
- Therapy Management, Medication
- Drug Therapy Management
- Management, Drug Therapy
- Therapy Management, Drug
|
Below are MeSH descriptors whose meaning is more general than "Medication Therapy Management".
Below are MeSH descriptors whose meaning is more specific than "Medication Therapy Management".
This graph shows the total number of publications written about "Medication Therapy Management" by people in this website by year, and whether "Medication Therapy Management" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 5 | 8 | 13 |
| 2018 | 8 | 5 | 13 |
| 2019 | 0 | 5 | 5 |
| 2020 | 6 | 7 | 13 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Medication Therapy Management" by people in Profiles.
-
[Safety in the selection of oral antibiotic treatment in community infections, beyond COVID-19]. Rev Esp Quimioter. 2021 Aug; 34(4):289-297.
-
Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down? Lancet Respir Med. 2021 08; 9(8):820-822.
-
Relatively mild symptoms after chronic overdose with a double-dose encorafenib: a case report. Anticancer Drugs. 2021 06 01; 32(5):589-591.
-
Challenges in Chronic Genetic Disorders: Lessons From the COVID-19 Pandemic. Indian Pediatr. 2021 Apr 15; 58(4):391-392.
-
Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view. Int Forum Allergy Rhinol. 2021 07; 11(7):1041-1046.
-
COVID-19 preparedness: A Bronx, New York, inner-city hospital's experience with medication management and readiness for a second surge. Am J Health Syst Pharm. 2021 03 05; 78(6):462-466.
-
Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age. Adv Ther. 2021 03; 38(3):1382-1396.
-
Role of community pharmacists in medication management during COVID-19 lockdown. Pathog Glob Health. 2021 05; 115(3):168-177.
-
A medication therapy management residency rotation adjusts to coronavirus disease 2019 constraints. J Am Pharm Assoc (2003). 2021 Jul-Aug; 61(4S):S7-S11.
-
Repurposing a Neurocritical Care Unit for the Management of Severely Ill Patients With COVID-19: A Retrospective Evaluation. J Neurosurg Anesthesiol. 2021 Jan; 33(1):77-81.